Characteristics and Analysis of Gut Microbiota in Sepsis-associated Acute Kidney Injury
By: Huaqing Liu, Wei Zhang, Yinghui Tian, Dawei Wang and Fei Liu
References
- Corte-Iglesias V, Saiz ML, Andrade-Lopez AC, Salazar N, Ruiz Bernet C, Martin-Martin C, Martinez Borra J-J, Lozano J-J, Aransay AM, Diaz-Corte C, et al. 2024. Propionate and butyrate counteract renal damage and progression to chronic kidney disease. Nephrol Dial Transplant. 40(1):133–150.
https://doi.org/10.1093/ndt/gfae118 - Evenepoel P, Poesen R, Meijers B. 2017. The gut-kidney axis. Pediatr Nephrol. 32(11):2005–2014.
https://doi.org/10.1007/s00467-016-3527-x - Fiorentino M, Philippe R, Palumbo CA, Prenna S, Cantaluppi V, De Rosa S. 2024. Epigenetic mechanisms in sepsis-associated acute kidney injury. Semin Respir Crit Care Med. 45(4):491–502.
https://doi.org/10.1055/s-0044-1789240 - Gao T, Nong Z, Luo Y, Mo M, Chen Z, Yang Z, Pan L. 2024. Machine learning-based prediction of in-hospital mortality for critically ill patients with sepsis-associated acute kidney injury. Ren Fail. 46(1):2316267.
https://doi.org/10.1080/0886022X.2024.2316267 - Huai J, Ye X. 2025. Dissecting causal relationships between gut microbiota, inflammatory factors, and acute kidney injury: a Mendelian randomization study. Clin Nephrol. 104(1):62–71.
https://doi.org/10.5414/CN111632 - Kong J, Yang J, He C, Zhou B, Fang S, Salinas M, Mohabbat AB, Bauer BA, Wang X. 2024. Regulation of endotoxemia through the gut microbiota: the role of the Mediterranean diet and its components. APMIS. 132(12):948–955.
https://doi.org/10.1111/apm.13473 - Kounatidis D, Tzivaki I, Daskalopoulou S, Daskou A, Adamou A, Rigatou A, Sdogkos E, Karampela I, Dalamaga M, Vallianou NG. 2024. Sepsis-associated acute kidney injury: what’s new regarding its diagnostics and therapeutics? Diagnostics (Basel). 14(24):2845.
https://doi.org/10.3390/diagnostics14242845 - Kullberg RFJ, Haak BW, Chanderraj R, Prescott HC, Dickson RP, Wiersinga WJ. 2025. Empirical antibiotic therapy for sepsis: save the anaerobic microbiota. Lancet Respir Med. 13(1):92–100.
https://doi.org/10.1016/S2213-2600(24)00257-1 - Lan T, Tang T, Li Y, Duan Y, Yuan Q, Liu W, Ren Y, Li N, Liu X, Zhang Y, et al. 2023. FTZ polysaccharides ameliorate kidney injury in diabetic mice by regulating gut-kidney axis. Phytomedicine. 118:154935.
https://doi.org/10.1016/j.phymed.2023.154935 - Li Q, Song XC, Li K, Wang J. 2025. Gut-lung immunometabolic crosstalk in sepsis: from microbiota to respiratory failure. Front Med (Lausanne). 12:1685044.
https://doi.org/10.3389/fmed.2025.1685044 - Liu AB., Tan B, Yang P, Tian N, Li JK., Wang SC., Yang LS., Ma L, Zhang JF. 2024. The role of inflammatory response and metabolic reprogramming in sepsis-associated acute kidney injury: mechanistic insights and therapeutic potential. Front. Immunol. 15:1487576.
https://doi.org/10.3389/fimmu.2024.1487576 - Liu W, Zhang Y, Hu D, Huang L, Liu X, Lu Z 2024. Oral astragalus polysaccharide alleviates adenine-induced kidney injury by regulating gut microbiota-short-chain fatty acids-kidney G protein-coupled receptors axis. Ren. Fail. 46(2):2429693.
https://doi.org/10.1080/0886022X.2024.2429693 - Luo Y, Gao J, Su X, Li H, Li Y, Qi W, Han X, Han J, Zhao Y, Zhang A, et al. 2025. Unraveling the immunological landscape and gut microbiome in sepsis: a comprehensive approach to diagnosis and prognosis. EBioMedicine 113:105586.
https://doi.org/10.1016/j.ebiom.2025.105586 - Luther T, Bülow-Anderberg S, Persson P, Franzén S, Skorup P, Wernerson A, Hultenby K, Palm F, Schiffer TA., Frithiof R 2023. Renal mitochondrial dysfunction in ovine experimental sepsis-associated acute kidney injury. Am. J. Physiol. Renal Physiol. 324(6):F571–F580.
https://doi.org/10.1152/ajprenal.00294.2022 - Mali N, Mali S, Zhang L, Fu P 2025. Interplay between gut microbiota and acute kidney injury: a review of their mutual influence and causation. Ren. Fail. 47(1):2522976.
https://doi.org/10.1080/0886022X.2025.2522976 - Noel S, Patel SK., White J, Verma D, Menez S, Raj D, Parikh C, Rabb H, Kidney Precision Medicine Project 2025. Metagenomic profiling of gut microbiota in kidney precision medicine project participants with CKD and AKI. Compr. Physiol. 15(5):e70058.
https://doi.org/10.1002/cph4.70058 - Odum JD., Hasson DC., Stanski NL., Gómez H, Soranno DE. 2025. The clinical view of sepsis-associated AKI: how basic science can help solve this problem. Semin. Nephrol. 45(6):151665.
https://doi.org/10.1016/j.semnephrol.2025.151665 - Ou L, Zhu Z, Hao Y, Li Q, Liu H, Chen Q, Peng C, Zhang C, Zou Y, Jia J, et al. 2024. 1,3,6-trigalloylglucose: a novel potent anti-Helicobacter pylori adhesion agent derived from aqueous extracts of Terminalia chebula Retz. Molecules 29(5):1161.
https://doi.org/10.3390/molecules29051161 - Pahl MV., Vaziri ND. 2015. The chronic kidney disease-colonic axis. Semin. Dial. 28(5):459–463.
https://doi.org/10.1111/sdi.12381 - Pan L, Yu H, Fu J, Hu J, Xu H, Zhang Z, Bu M, Yang X, Zhang H, Lu J, et al. 2023. Berberine ameliorates chronic kidney disease through inhibiting the production of gut-derived uremic toxins in the gut microbiota. Acta Pharm. Sin. B 13(4):1537–1553.
https://doi.org/10.1016/j.apsb.2022.12.010 - Saranya GR., Viswanathan P 2023. Gut microbiota dysbiosis in AKI to CKD transition. Biomed. Pharmacother. 161:114447.
https://doi.org/10.1016/j.biopha.2023.114447 - Shi B, Ye J, Chen W, Liao B, Gu W, Yin H, Lyu J 2025. Prognosis of critically ill patients with early and late sepsis-associated acute kidney injury: an observational study based on the MIMIC-IV. Ren. Fail. 47(1):2441393.
https://doi.org/10.1080/0886022X.2024.2441393 - Singer M, Deutschman CS., Seymour CW., Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR., Chiche JD., Coopersmith CM., et al. 2016. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315(8):801–810.
https://doi.org/10.1001/jama.2016.0287 - Sun X, Wei Z, Liu Y, Li F, Liu X, Ding Q, Ding Z, Liu J, Sun Q 2025. Structural features and efficacy of polysaccharide EPS22 from Klebsiella sp. S22 in mitigating cisplatin-induced acute kidney injury. Int. J. Biol. Macromol. 311(Pt 3):143944.
https://doi.org/10.1016/j.ijbiomac.2025.143944 - Takeuchi T, Flannery AH., Liu LJ., Ghazi L, Cama-Olivares A, Fushimi K, Chen J, Huen SC., Tolwani AJ., Neyra JA. 2025. Epidemiology of sepsis-associated acute kidney injury in the ICU with contemporary consensus definitions. Crit. Care 29(1):128.
https://doi.org/10.1186/s13054-025-05351-5 - Tanoue K, Kinoshita M, Kearney BM., Ito S, Goto H, Yamashiro A, Fukunaga T, Sato H, Mori K, Kuwata K, et al. 2025. Lipopolysaccharide preconditioning augments the antibacterial activity of renal macrophages and ameliorates acute kidney injury caused by Staphylococcus aureus bacteremia in mice. Innate Immun. 31:17534259251335770.
https://doi.org/10.1177/17534259251335770 - Tian X, Yuan L, Zeng Y 2025. Butyrate attenuates SA-AKI by inhibiting pyroptosis via the STING-GSDMD axis. Biochem. Biophys. Res. Commun. 743:151143.
https://doi.org/10.1016/j.bbrc.2024.151143 - Tyc O, Kraus N, Wiedemann T, Erasmus HP., Ortiz C, Vasseur J, Hourfar K, Seidl C, Mücke MM., Storf H, et al. 2025. Enterococcus faecium DNA in acute decompensated cirrhosis: a key player in inflammation and kidney dysfunction. Front. Med. (Lausanne) 12:1629210.
https://doi.org/10.3389/fmed.2025.1629210 - Wakino S, Hasegawa K, Tamaki M, Minato M, Inagaki T 2025. Kidney-gut axis in chronic kidney disease: therapeutic perspectives from microbiota modulation and nutrition. Nutrients 17(12):1961.
https://doi.org/10.3390/nu17121961 - Wang F, Ye J, Zhu W, Ge R, Hu C, Qian Y, Li Y, Peng Z 2024. Galectin-3 mediates endotoxin internalization and caspase-4/11 activation in tubular epithelials and macrophages during sepsis and sepsis-associated acute kidney injury. Inflammation 47(1):454–468.
https://doi.org/10.1007/s10753-023-01928-w - Wang FQ., Jiang HL., Cheng SL. 2012. Intestinal-renal syndrome and chronic kidney disease. Chinese Journal of Nephrology, Dialysis & Transplantation.
- Wang ML., Zhang YJ., Xiao H, Lu XL., Chen L, Ma ZW., Chen A, Yin Q 2025. Probiotic effects of Clostridium cellabutyricum against Pseudomonas aeruginosa infection in an antibiotic-induced gut microbial dysbiosis mouse model. Int. J. Antimicrob. Agents 66(1):107503. DOI incomplete in source:
https://doi.org/10.1016/j.ijantimicag.2025 - Xu P 2025. Gut microbiota metabolites targeting the immune response in sepsis: mechanisms and therapies. Int. J. Gen. Med. 18:4709–4734.
https://doi.org/10.2147/IJGM.S539237 - Zhang Q, Yang B, Li X, Zhao Y, Yang S, Ma Q, Cui L 2025. Biomarkers of cell cycle arrest, microcirculation dysfunction, and inflammation in the prediction of SA-AKI. Sci. Rep. 15(1):8023.
https://doi.org/10.1038/s41598-025-92315-y
Language: English
Page range: 306 - 318
Submitted on: Mar 9, 2026
Accepted on: Jun 21, 2026
Published on: Sep 30, 2026
Published by: Polish Society of Microbiologists
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2026 Huaqing Liu, Wei Zhang, Yinghui Tian, Dawei Wang, Fei Liu, published by Polish Society of Microbiologists
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.